These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
525 related articles for article (PubMed ID: 11955451)
1. Causal relationship between the loss of RUNX3 expression and gastric cancer. Li QL; Ito K; Sakakura C; Fukamachi H; Inoue Ki; Chi XZ; Lee KY; Nomura S; Lee CW; Han SB; Kim HM; Kim WJ; Yamamoto H; Yamashita N; Yano T; Ikeda T; Itohara S; Inazawa J; Abe T; Hagiwara A; Yamagishi H; Ooe A; Kaneda A; Sugimura T; Ushijima T; Bae SC; Ito Y Cell; 2002 Apr; 109(1):113-24. PubMed ID: 11955451 [TBL] [Abstract][Full Text] [Related]
2. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD. Chi XZ; Yang JO; Lee KY; Ito K; Sakakura C; Li QL; Kim HR; Cha EJ; Lee YH; Kaneda A; Ushijima T; Kim WJ; Ito Y; Bae SC Mol Cell Biol; 2005 Sep; 25(18):8097-107. PubMed ID: 16135801 [TBL] [Abstract][Full Text] [Related]
3. Growth regulation of gastric epithelial cells by Runx3. Fukamachi H; Ito K Oncogene; 2004 May; 23(24):4330-5. PubMed ID: 15156189 [TBL] [Abstract][Full Text] [Related]
4. Runx3-/- gastric epithelial cells differentiate into intestinal type cells. Fukamachi H; Ito K; Ito Y Biochem Biophys Res Commun; 2004 Aug; 321(1):58-64. PubMed ID: 15358215 [TBL] [Abstract][Full Text] [Related]
5. The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis. Yano T; Ito K; Fukamachi H; Chi XZ; Wee HJ; Inoue K; Ida H; Bouillet P; Strasser A; Bae SC; Ito Y Mol Cell Biol; 2006 Jun; 26(12):4474-88. PubMed ID: 16738314 [TBL] [Abstract][Full Text] [Related]
6. Hypermethylation downregulates Runx3 gene expression and its restoration suppresses gastric epithelial cell growth by inducing p27 and caspase3 in human gastric cancer. Chen W; Gao N; Shen Y; Cen JN J Gastroenterol Hepatol; 2010 Apr; 25(4):823-31. PubMed ID: 20492341 [TBL] [Abstract][Full Text] [Related]
7. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers. Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423 [TBL] [Abstract][Full Text] [Related]
8. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma. Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Ito Y; Chayama K; Yasui W Pathobiology; 2004; 71(3):137-43. PubMed ID: 15051926 [TBL] [Abstract][Full Text] [Related]
9. Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer. Sakakura C; Hagiwara A; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Ito K; Yamagishi H; Yazumi S; Chiba T; Ito Y Int J Cancer; 2005 Jan; 113(2):221-8. PubMed ID: 15386419 [TBL] [Abstract][Full Text] [Related]
10. Runx3 controls growth and differentiation of gastric epithelial cells in mammals. Fukamachi H Dev Growth Differ; 2006 Jan; 48(1):1-13. PubMed ID: 16466388 [TBL] [Abstract][Full Text] [Related]
11. Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia. Waki T; Tamura G; Sato M; Terashima M; Nishizuka S; Motoyama T Cancer Sci; 2003 Apr; 94(4):360-4. PubMed ID: 12824905 [TBL] [Abstract][Full Text] [Related]
12. GASDERMIN, suppressed frequently in gastric cancer, is a target of LMO1 in TGF-beta-dependent apoptotic signalling. Saeki N; Kim DH; Usui T; Aoyagi K; Tatsuta T; Aoki K; Yanagihara K; Tamura M; Mizushima H; Sakamoto H; Ogawa K; Ohki M; Shiroishi T; Yoshida T; Sasaki H Oncogene; 2007 Oct; 26(45):6488-98. PubMed ID: 17471240 [TBL] [Abstract][Full Text] [Related]
13. RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization. Ito K; Liu Q; Salto-Tellez M; Yano T; Tada K; Ida H; Huang C; Shah N; Inoue M; Rajnakova A; Hiong KC; Peh BK; Han HC; Ito T; Teh M; Yeoh KG; Ito Y Cancer Res; 2005 Sep; 65(17):7743-50. PubMed ID: 16140942 [TBL] [Abstract][Full Text] [Related]
15. Lineage-specific RUNX3 hypomethylation marks the preneoplastic immune component of gastric cancer. Kurklu B; Whitehead RH; Ong EK; Minamoto T; Fox JG; Mann JR; Judd LM; Giraud AS; Menheniott TR Oncogene; 2015 May; 34(22):2856-66. PubMed ID: 25088199 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor. Guo WH; Weng LQ; Ito K; Chen LF; Nakanishi H; Tatematsu M; Ito Y Oncogene; 2002 Nov; 21(54):8351-5. PubMed ID: 12447699 [TBL] [Abstract][Full Text] [Related]
17. Frequent loss of RUNX3 gene expression in remnant stomach cancer and adjacent mucosa with special reference to topography. Nakase Y; Sakakura C; Miyagawa K; Kin S; Fukuda K; Yanagisawa A; Koide K; Morofuji N; Hosokawa Y; Shimomura K; Katsura K; Hagiwara A; Yamagishi H; Ito K; Ito Y Br J Cancer; 2005 Feb; 92(3):562-9. PubMed ID: 15685235 [TBL] [Abstract][Full Text] [Related]
18. Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression. Lu XX; Yu JL; Ying LS; Han J; Wang S; Yu QM; Wang XB; Fang XH; Ling ZQ Cancer; 2012 Nov; 118(22):5507-17. PubMed ID: 22576578 [TBL] [Abstract][Full Text] [Related]
19. Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia. Brenner O; Levanon D; Negreanu V; Golubkov O; Fainaru O; Woolf E; Groner Y Proc Natl Acad Sci U S A; 2004 Nov; 101(45):16016-21. PubMed ID: 15514019 [TBL] [Abstract][Full Text] [Related]
20. RUNX3 inhibits cell proliferation and induces apoptosis by reinstating transforming growth factor beta responsiveness in esophageal adenocarcinoma cells. Torquati A; O'rear L; Longobardi L; Spagnoli A; Richards WO; Daniel Beauchamp R Surgery; 2004 Aug; 136(2):310-6. PubMed ID: 15300196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]